Advertisement

Latest News

Diabetes Dialogue: SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD

13 hours ago

In this episode, hosts are joined by co-chair of the SELECT steering committee A. Michael Lincoff, MD, to discuss results, potential explanations for cardiovascular benefit beyond weight reduction, FLOW trials implications, and the future of incretin therapies.

Clinical Quiz: AGA Guideline for Fecal Microbiota-Based Therapies in Gastrointestinal Disease

18 hours ago

Test your knowledge of the AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases with this clinical quiz!

Biosimilars Month in Review: February 2024

March 02, 2024

This month’s biosimilars month in review highlights the evolving landscape of biosimilars, emphasizing their potential benefits in terms of safety, cost-effectiveness, and increased treatment options, while recognizing the importance of addressing challenges in adoption and perception.

Hematologic Parameters Predict Benefit of Baricitinib in COVID-19 Hospitalizations

March 01, 2024

In a post hoc analysis of the ACCT-2 study, a risk profile using simple hematologic parameters identified patients hospitalized with COVID-19 who benefited most from baricitinib treatment.

Rheumatology Month in Review: February 2024

March 01, 2024

The rheumatology month in review highlights cognitive dysfunction in patients with fibromyalgia, explores the impact of obesity on treatment response in rheumatoid arthritis, and evaluates work-related challenges faced by patients with psoriatic arthritis.

Advertisement
Advertisement